AAM
MRNA icon

Azzad Asset Management’s Moderna MRNA Stock Holding History

Azzad Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,789
Closed -$689K – 337
2021
Q3 		$689K Buy
1,789
+300
+20% +$111K 0.1% 263
2021
Q2 		$350K Buy
+1,489
New +$266K 0.05% 295

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Azzad Asset Management's MRNA Position: Q4 2021 in Review

Azzad Asset Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 1,789 shares — an estimated $689K sold.

Azzad Asset Management first reported a position in MRNA in Q2 2021 and held it in 2 quarters. The position peaked at $689K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Azzad Asset Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Azzad Asset Management sold 1,789 Moderna shares in Q4 2021, an estimated $689K.
  • Azzad Asset Management first reported a position in Moderna in Q2 2021 and held it in 2 quarters.
  • Azzad Asset Management's Moderna position peaked at $689K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Azzad Asset Management's 13F filing for Q4 2021, filed 1 Apr 2024.